Initial escalation day | |
---|---|
Escalations performed | 25 |
Reactions | 13 (52%) |
Mild (Grade 1) | 13 (52%) |
Moderate (Grade 2) | 0 |
Severe (Grade 3) | 0 |
Epinephrine use | 0 |
Dose escalations | |
Doses administered | 227 |
Reactions | 13 (5.7%) |
Mild (Grade 1) | 13 (5.7%) |
Moderate (Grade 2) | 0 |
Severe (Grade 3) | 0 |
Median reaction rate [range] | 0% [0–25] |
Epinephrine use | 0 |
Home dosing | |
Doses administered | 7530 |
Reactions | 401 (5.3%) |
Mild (Grade 1) | 385 (5.1%) |
Moderate (Grade 2) | 15 (0.2%) |
Severe (Grade 3) | 1 (0.01%) |
Median reaction rate [range] | 3.2% [0.1-18.5] |
Epinephrine use | 1 (0.01%) |